Calliditas Therapeutics Dividend
Dividend criteria checks 0/6
Calliditas Therapeutics does not have a record of paying a dividend.
Key information
n/a
Dividend yield
n/a
Payout ratio
| Industry average yield | 2.2% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Earnings per share | -US$9.78 |
| Dividend yield forecast in 3Y | 0% |
Recent dividend updates
No updates
Recent updates
Asahi Kasei To Pay A Fair Price For Calliditas Therapeutics
May 28Calliditas Therapeutics GAAP EPS of -SEK 3.62, revenue of SEK 64M
Aug 18Calliditas Therapeutics wins European approval for Kinpeygo for IgA nephropathy
Jul 15Calliditas submits nefecon marketing authorisation application to the EMA
May 28Calliditas shares rise 10% as FDA grants priority review for Nefecon
Apr 28Calliditas Therapeutics reports Q3 results
Nov 12Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if CALT's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if CALT's dividend payments have been increasing.
Dividend Yield vs Market
| Calliditas Therapeutics Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (CALT) | n/a |
| Market Bottom 25% (US) | 1.5% |
| Market Top 25% (US) | 4.8% |
| Industry Average (Pharmaceuticals) | 2.2% |
| Analyst forecast in 3 Years (CALT) | 0% |
Notable Dividend: Unable to evaluate CALT's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate CALT's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate CALT's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as CALT has not reported any payouts.